Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Diekmann

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Oncoimmunology|October 20, 2023
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibodyHayat Bähr-Mahmud, Ursula Ellinghaus, Christiane R Stadler, et al.
Nature|July 22, 2014
A vaccine targeting mutant IDH1 induces antitumour immunityTheresa Schumacher, Lukas Bunse, Stefan Pusch, et al.
Nature|June 10, 2016
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapyLena M Kranz, Mustafa Diken, Heinrich Haas, et al.
Science Translational Medicine|September 13, 2021
Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor modelsChristian Hotz, Timothy R Wagenaar, Friederike Gieseke, et al.
Nature|July 6, 2017
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancerUgur Sahin, Evelyna Derhovanessian, Matthias Miller, et al.
Nature Medicine|January 6, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialJuanita Lopez, Thomas Powles, Fadi Braiteh, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Oncoimmunology|October 20, 2023
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibodyHayat Bähr-Mahmud, Ursula Ellinghaus, Christiane R Stadler, et al.
Nature|July 22, 2014
A vaccine targeting mutant IDH1 induces antitumour immunityTheresa Schumacher, Lukas Bunse, Stefan Pusch, et al.
Nature|June 10, 2016
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapyLena M Kranz, Mustafa Diken, Heinrich Haas, et al.
Science Translational Medicine|September 13, 2021
Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor modelsChristian Hotz, Timothy R Wagenaar, Friederike Gieseke, et al.
Nature|July 6, 2017
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancerUgur Sahin, Evelyna Derhovanessian, Matthias Miller, et al.
Nature Medicine|January 6, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialJuanita Lopez, Thomas Powles, Fadi Braiteh, et al.
Pageof 2